Skip to main content
NCBI home page
Transactions of the American Clinical and Climatological Association logoLink to Transactions of the American Clinical and Climatological Association
. 1989;100:142–154.

Primary biliary cirrhosis: new perspectives.

W C Maddrey 1
PMCID: PMC2376463  PMID: 3077573

Full text

PDF
142

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berg P. A., Klein R., Lindenborn-Fotinos J. Antimitochondrial antibodies in primary biliary cirrhosis. J Hepatol. 1986;2(1):123–131. doi: 10.1016/s0168-8278(86)80015-0. [DOI] [PubMed] [Google Scholar]
  2. Beswick D. R., Klatskin G., Boyer J. L. Asymptomatic primary biliary cirrhosis. A progress report on long-term follow-up and natural history. Gastroenterology. 1985 Aug;89(2):267–271. [PubMed] [Google Scholar]
  3. Boyer J. L. Mechanisms of chlorpromazine cholestasis: hypersensitivity or toxic metabolite? Gastroenterology. 1978 Jun;74(6):1331–1333. [PubMed] [Google Scholar]
  4. Chohan M. R. Primary biliary cirrhosis in twin sisters. Gut. 1973 Mar;14(3):213–214. doi: 10.1136/gut.14.3.213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Christensen E., Neuberger J., Crowe J., Altman D. G., Popper H., Portmann B., Doniach D., Ranek L., Tygstrup N., Williams R. Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial. Gastroenterology. 1985 Nov;89(5):1084–1091. doi: 10.1016/0016-5085(85)90213-6. [DOI] [PubMed] [Google Scholar]
  6. Cohen L. B., Ambinder E. P., Wolke A. M., Field S. P., Schaffner F. Role of plasmapheresis in primary biliary cirrhosis. Gut. 1985 Mar;26(3):291–294. doi: 10.1136/gut.26.3.291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dickson E. R., Fleming T. R., Wiesner R. H., Baldus W. P., Fleming C. R., Ludwig J., McCall J. T. Trial of penicillamine in advanced primary biliary cirrhosis. N Engl J Med. 1985 Apr 18;312(16):1011–1015. doi: 10.1056/NEJM198504183121602. [DOI] [PubMed] [Google Scholar]
  8. Elta G. H., Sepersky R. A., Goldberg M. J., Connors C. M., Miller K. B., Kaplan M. M. Increased incidence of hypothyroidism in primary biliary cirrhosis. Dig Dis Sci. 1983 Nov;28(11):971–975. doi: 10.1007/BF01311724. [DOI] [PubMed] [Google Scholar]
  9. Epstein O., Thomas H. C., Sherlock S. Primary biliary cirrhosis is a dry gland syndrome with features of chronic graft-versus-host disease. Lancet. 1980 May 31;1(8179):1166–1168. doi: 10.1016/s0140-6736(80)91621-9. [DOI] [PubMed] [Google Scholar]
  10. Esquivel C. O., Van Thiel D. H., Demetris A. J., Bernardos A., Iwatsuki S., Markus B., Gordon R. D., Marsh J. W., Makowka L., Tzakis A. G. Transplantation for primary biliary cirrhosis. Gastroenterology. 1988 May;94(5 Pt 1):1207–1216. doi: 10.1016/0016-5085(88)90014-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Galbraith R. M., Smith M., Mackenzie R. M., Tee D. E., Doniach D., Williams R. High prevalence of seroimmunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis. N Engl J Med. 1974 Jan 10;290(2):63–69. doi: 10.1056/NEJM197401102900201. [DOI] [PubMed] [Google Scholar]
  12. Gershwin M. E., Coppel R. L., Mackay I. R. Primary biliary cirrhosis and mitochondrial autoantigens--insights from molecular biology. Hepatology. 1988 Jan-Feb;8(1):147–151. doi: 10.1002/hep.1840080128. [DOI] [PubMed] [Google Scholar]
  13. Ghent C. N., Carruthers S. G. Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial. Gastroenterology. 1988 Feb;94(2):488–493. doi: 10.1016/0016-5085(88)90442-8. [DOI] [PubMed] [Google Scholar]
  14. Golding P. L., Smith M., Williams R. Multisystem involvement in chronic liver disease. Studies on the incidence and pathogenesis. Am J Med. 1973 Dec;55(6):772–782. doi: 10.1016/0002-9343(73)90258-1. [DOI] [PubMed] [Google Scholar]
  15. Herlong H. F., Recker R. R., Maddrey W. C. Bone disease in primary biliary cirrhosis: histologic features and response to 25-hydroxyvitamin D. Gastroenterology. 1982 Jul;83(1 Pt 1):103–108. [PubMed] [Google Scholar]
  16. Herlong H. F., Russell R. M., Maddrey W. C. Vitamin A and zinc therapy in primary biliary cirrhosis. Hepatology. 1981 Jul-Aug;1(4):348–351. doi: 10.1002/hep.1840010412. [DOI] [PubMed] [Google Scholar]
  17. Hodgson S. F., Dickson E. R., Wahner H. W., Johnson K. A., Mann K. G., Riggs B. L. Bone loss and reduced osteoblast function in primary biliary cirrhosis. Ann Intern Med. 1985 Dec;103(6 ):855–860. doi: 10.7326/0003-4819-103-6-855. [DOI] [PubMed] [Google Scholar]
  18. Howat H. T., Ralston A. J., Varley H., Wilson J. A. The late results of long-term treatment of primary biliary cirrhosis by corticosteroids. Rev Int Hepatol. 1966;16(2):227–238. [PubMed] [Google Scholar]
  19. Jahn C. E., Schaefer E. J., Taam L. A., Hoofnagle J. H., Lindgren F. T., Albers J. J., Jones E. A., Brewer H. B., Jr Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterification. Gastroenterology. 1985 Dec;89(6):1266–1278. [PubMed] [Google Scholar]
  20. Javitt N. B. Letter: Timing of cholestyramine doses in cholestatic liver disease. N Engl J Med. 1974 Jun 6;290(23):1328–1329. doi: 10.1056/nejm197406062902326. [DOI] [PubMed] [Google Scholar]
  21. Kapelman B., Schaffner F. The natural history of primary biliary cirrhosis. Semin Liver Dis. 1981 Nov;1(4):273–281. doi: 10.1055/s-2008-1040731. [DOI] [PubMed] [Google Scholar]
  22. Kaplan M. M., Elta G. H., Furie B., Sadowski J. A., Russell R. M. Fat-soluble vitamin nutriture in primary biliary cirrhosis. Gastroenterology. 1988 Sep;95(3):787–792. doi: 10.1016/s0016-5085(88)80029-5. [DOI] [PubMed] [Google Scholar]
  23. Kaplan M. M., Knox T. A., Arora S. A. Primary biliary cirrhosis treated with low-dose oral pulse methotrexate. Ann Intern Med. 1988 Sep 1;109(5):429–431. doi: 10.7326/0003-4819-109-5-429. [DOI] [PubMed] [Google Scholar]
  24. Kaplan M. M. Primary biliary cirrhosis. N Engl J Med. 1987 Feb 26;316(9):521–528. doi: 10.1056/NEJM198702263160907. [DOI] [PubMed] [Google Scholar]
  25. Klatskin G., Kantor F. S. Mitochondrial antibody in primary biliary cirrhosis and other diseases. Ann Intern Med. 1972 Oct;77(4):533–541. doi: 10.7326/0003-4819-77-4-533. [DOI] [PubMed] [Google Scholar]
  26. Klein R., Klöppel G., Fischer R., Fintelmann V., Müting D., Berg P. A. The antimitochondrial antibody anti-M9. A marker for the diagnosis of early primary biliary cirrhosis. J Hepatol. 1988 Jun;6(3):299–306. doi: 10.1016/s0168-8278(88)80046-1. [DOI] [PubMed] [Google Scholar]
  27. LLOYD-THOMAS H. G. L., SHERLOCK S. Testosterone therapy for the pruritus of obstructive jaundice. Br Med J. 1952 Dec 13;2(4797):1289–1291. doi: 10.1136/bmj.2.4797.1289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Lanspa S. J., Chan A. T., Bell J. S., 3rd, Go V. L., Dickson E. R., DiMagno E. P. Pathogenesis of steatorrhea in primary biliary cirrhosis. Hepatology. 1985 Sep-Oct;5(5):837–842. doi: 10.1002/hep.1840050522. [DOI] [PubMed] [Google Scholar]
  29. Lee R. G., Epstein O., Jauregui H., Sherlock S., Scheuer P. J. Granulomas in primary biliary cirrhosis: a prognostic feature. Gastroenterology. 1981 Dec;81(6):983–986. [PubMed] [Google Scholar]
  30. Lindgren S., Eriksson S. IgM in primary biliary cirrhosis. Physicochemical and complement activating properties. J Lab Clin Med. 1982 May;99(5):636–645. [PubMed] [Google Scholar]
  31. Lindgren S., Johnson U. Complement activation in primary biliary cirrhosis: an in vitro model. J Lab Clin Med. 1985 Apr;105(4):432–435. [PubMed] [Google Scholar]
  32. Long R. G., Scheuer P. J., Sherlock S. Presentation and course of asymptomatic primary biliary cirrhosis. Gastroenterology. 1977 Jun;72(6):1204–1207. [PubMed] [Google Scholar]
  33. Ludwig J., Dickson E. R., McDonald G. S. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol. 1978 Aug 22;379(2):103–112. doi: 10.1007/BF00432479. [DOI] [PubMed] [Google Scholar]
  34. Ludwig J. New concepts in biliary cirrhosis. Semin Liver Dis. 1987 Nov;7(4):293–301. doi: 10.1055/s-2008-1040584. [DOI] [PubMed] [Google Scholar]
  35. Maddrey W. C. Sarcoidosis and primary biliary cirrhosis. Associated disorders? N Engl J Med. 1983 Mar 10;308(10):588–590. doi: 10.1056/NEJM198303103081011. [DOI] [PubMed] [Google Scholar]
  36. Miller K. B., Sepersky R. A., Brown K. M., Goldberg M. J., Kaplan M. M. Genetic abnormalities of immunoregulation in primary biliary cirrhosis. Am J Med. 1983 Jul;75(1):75–80. doi: 10.1016/0002-9343(83)91170-1. [DOI] [PubMed] [Google Scholar]
  37. Minuk G. Y., Bohme C. E., Burgess E., Hershfield N. B., Kelly J. K., Shaffer E. A., Sutherland L. R., Van Rosendaal G. Pilot study of cyclosporin A in patients with symptomatic primary biliary cirrhosis. Gastroenterology. 1988 Nov;95(5):1356–1363. doi: 10.1016/0016-5085(88)90373-3. [DOI] [PubMed] [Google Scholar]
  38. Nakanuma Y., Ohta G. Histometric and serial section observations of the intrahepatic bile ducts in primary biliary cirrhosis. Gastroenterology. 1979 Jun;76(6):1326–1332. [PubMed] [Google Scholar]
  39. Neuberger J., Portmann B., Macdougall B. R., Calne R. Y., Williams R. Recurrence of primary biliary cirrhosis after liver transplantation. N Engl J Med. 1982 Jan 7;306(1):1–4. doi: 10.1056/NEJM198201073060101. [DOI] [PubMed] [Google Scholar]
  40. Nouri-Aria K. T., Hegarty J. E., Neuberger J., Eddleston A. L., Williams R. In vitro studies on the mechanism of increased serum IgM levels in primary biliary cirrhosis. Clin Exp Immunol. 1985 Aug;61(2):297–304. [PMC free article] [PubMed] [Google Scholar]
  41. Olomu A. B., Vickers C. R., Waring R. H., Clements D., Babbs C., Warnes T. W., Elias E. High incidence of poor sulfoxidation in patients with primary biliary cirrhosis. N Engl J Med. 1988 Apr 28;318(17):1089–1092. doi: 10.1056/NEJM198804283181703. [DOI] [PubMed] [Google Scholar]
  42. Portmann B., Popper H., Neuberger J., Williams R. Sequential and diagnostic features in primary biliary cirrhosis based on serial histologic study in 209 patients. Gastroenterology. 1985 Jun;88(6):1777–1790. doi: 10.1016/0016-5085(85)90001-0. [DOI] [PubMed] [Google Scholar]
  43. Poupon R., Chrétien Y., Poupon R. E., Ballet F., Calmus Y., Darnis F. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? Lancet. 1987 Apr 11;1(8537):834–836. doi: 10.1016/s0140-6736(87)91610-2. [DOI] [PubMed] [Google Scholar]
  44. Powell F. C., Schroeter A. L., Dickson E. R. Primary biliary cirrhosis and the CREST syndrome: a report of 22 cases. Q J Med. 1987 Jan;62(237):75–82. [PubMed] [Google Scholar]
  45. Reynolds T. B., Denison E. K., Frankl H. D., Lieberman F. L., Peters R. L. Primary biliary cirrhosis with scleroderma, Raynaud's phenomenon and telangiectasia. New syndrome. Am J Med. 1971 Mar;50(3):302–312. doi: 10.1016/0002-9343(71)90218-x. [DOI] [PubMed] [Google Scholar]
  46. Roll J., Boyer J. L., Barry D., Klatskin G. The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis. N Engl J Med. 1983 Jan 6;308(1):1–7. doi: 10.1056/NEJM198301063080101. [DOI] [PubMed] [Google Scholar]
  47. Ros E., García-Pugés A., Reixach M., Cusó E., Rodés J. Fat digestion and exocrine pancreatic function in primary biliary cirrhosis. Gastroenterology. 1984 Jul;87(1):180–187. [PubMed] [Google Scholar]
  48. Ros E., García-Pugés A., Reixach M., Cusó E., Rodés J. Fat digestion and exocrine pancreatic function in primary biliary cirrhosis. Gastroenterology. 1984 Jul;87(1):180–187. [PubMed] [Google Scholar]
  49. Rubel L. R., Rabin L., Seeff L. B., Licht H., Cuccherini B. A. Does primary biliary cirrhosis in men differ from primary biliary cirrhosis in women? Hepatology. 1984 Jul-Aug;4(4):671–677. doi: 10.1002/hep.1840040418. [DOI] [PubMed] [Google Scholar]
  50. Scheuer P. Primary biliary cirrhosis. Proc R Soc Med. 1967 Dec;60(12):1257–1260. doi: 10.1177/003591576706001205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Shapiro J. M., Smith H., Schaffner F. Serum bilirubin: a prognostic factor in primary biliary cirrhosis. Gut. 1979 Feb;20(2):137–140. doi: 10.1136/gut.20.2.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Si L., Whiteside T. L., Schade R. R., Starzl T. E., Van Thiel D. H. T-lymphocyte subsets in liver tissues of patients with primary biliary cirrhosis (PBC), patients with primary sclerosing cholangitis (PSC), and normal controls. J Clin Immunol. 1984 Jul;4(4):262–272. doi: 10.1007/BF00915293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Stemerowicz R., Hopf U., Möller B., Wittenbrink C., Rodloff A., Reinhardt R., Freudenberg M., Galanos C. Are antimitochondrial antibodies in primary biliary cirrhosis induced by R(rough)-mutants of enterobacteriaceae? Lancet. 1988 Nov 19;2(8621):1166–1170. doi: 10.1016/s0140-6736(88)90235-8. [DOI] [PubMed] [Google Scholar]
  54. Tong M. J., Nies K. M., Reynolds T. B., Quismorio F. P. Immunological studies in familial primary biliary cirrhosis. Gastroenterology. 1976 Aug;71(2):305–307. [PubMed] [Google Scholar]
  55. Walker C. O., Combes B. Biliary cirrhosis induced by chlorpromazine. Gastroenterology. 1966 Nov;51(5):631–640. [PubMed] [Google Scholar]
  56. Warnes T. W., Smith A., Lee F. I., Haboubi N. Y., Johnson P. J., Hunt L. A controlled trial of colchicine in primary biliary cirrhosis. Trial design and preliminary report. J Hepatol. 1987 Aug;5(1):1–7. doi: 10.1016/s0168-8278(87)80053-3. [DOI] [PubMed] [Google Scholar]
  57. Zeegen R., Stansfeld A. G., Dawson A. M., Hunt A. H. Bleeding oesophageal varices as the presenting feature in primary bilirary cirrhosis. Lancet. 1969 Jul 5;2(7610):9–12. doi: 10.1016/s0140-6736(69)92595-1. [DOI] [PubMed] [Google Scholar]

Articles from Transactions of the American Clinical and Climatological Association are provided here courtesy of American Clinical and Climatological Association

RESOURCES